IMUX – immunic, inc. (US:NASDAQ)

News

Immunic, Inc. (NASDAQ: IMUX) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $17.00 price target on the stock.
Immunic Highlights 2024 Accomplishments and Upcoming Milestones [Yahoo! Finance]
Immunic Highlights 2024 Accomplishments and Upcoming Milestones
Immunic, Inc. to Participate in Investor Conference in December [Yahoo! Finance]
Immunic, Inc. to Participate in Investor Conference in December
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com